Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-08-01 Schenkein David P Chief Executive Officer Sale −3,000 $55.12 $165K 0
2017-08-01 Schenkein David P Chief Executive Officer Option exercise · Stock option (right to buy) −3,000 183,656
2017-07-20 Cantley Lewis Clayton Jr. Director Sale −500 $57.12 $29K 85,697
2017-07-20 Cantley Lewis Clayton Jr. Director Sale −500 $57.12 $29K 85,737
2017-07-20 Cantley Lewis Clayton Jr. Director Sale −500 $57.13 $29K 85,197
2017-07-20 Cantley Lewis Clayton Jr. Director Sale −500 $57.13 $29K 85,237
2017-07-19 Cantley Lewis Clayton Jr. Director Sale −3,000 $56.15 $168K 86,697
2017-07-19 Cantley Lewis Clayton Jr. Director Sale −3,000 $56.15 $168K 86,737
2017-07-19 Cantley Lewis Clayton Jr. Director Sale −500 $56.11 $28K 86,197
2017-07-19 Cantley Lewis Clayton Jr. Director Sale −500 $56.11 $28K 86,237
2017-07-07 Biller Scott Chief Scientific Officer Option exercise +2,146 $9.05 $19K 8,410
2017-07-07 Biller Scott Chief Scientific Officer Sale −2,146 $55.00 $118K 6,264
2017-07-07 Biller Scott Chief Scientific Officer Option exercise · Stock option (right to buy) −2,146 39,573
2017-07-03 Schenkein David P Chief Executive Officer Option exercise +3,000 $0.30 $908 3,000
2017-07-03 Schenkein David P Chief Executive Officer Sale −3,000 $51.18 $154K 0
2017-07-03 Schenkein David P Chief Executive Officer Option exercise · Stock option (right to buy) −3,000 186,656
2017-06-23 Biller Scott Chief Scientific Officer Option exercise +3,000 $0.47 $1K 6,264
2017-06-23 Biller Scott Chief Scientific Officer Option exercise · Stock option (right to buy) −3,000 14,875
2017-06-21 Biller Scott Chief Scientific Officer Option exercise +4,292 $9.05 $39K 4,556
2017-06-21 Biller Scott Chief Scientific Officer Sale −4,292 $55.00 $236K 264

Page 74 of 80 · 1,590 trades